Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies.

Katsumata K, Ishihara J, Mansurov A, Ishihara A, Raczy MM, Yuba E, Hubbell JA.

Sci Adv. 2019 Nov 6;5(11):eaay1971. doi: 10.1126/sciadv.aay1971. eCollection 2019 Nov.

2.

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes.

Wilson DS, Damo M, Hirosue S, Raczy MM, Br├╝nggel K, Diaceri G, Quaglia-Thermes X, Hubbell JA.

Nat Biomed Eng. 2019 Oct;3(10):817-829. doi: 10.1038/s41551-019-0424-1. Epub 2019 Jul 29.

PMID:
31358881
3.

Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Ishihara J, Ishihara A, Sasaki K, Lee SS, Williford JM, Yasui M, Abe H, Potin L, Hosseinchi P, Fukunaga K, Raczy MM, Gray LT, Mansurov A, Katsumata K, Fukayama M, Kron SJ, Swartz MA, Hubbell JA.

Sci Transl Med. 2019 Apr 10;11(487). pii: eaau3259. doi: 10.1126/scitranslmed.aau3259.

4.

Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity.

Wilson DS, Hirosue S, Raczy MM, Bonilla-Ramirez L, Jeanbart L, Wang R, Kwissa M, Franetich JF, Broggi MAS, Diaceri G, Quaglia-Thermes X, Mazier D, Swartz MA, Hubbell JA.

Nat Mater. 2019 Feb;18(2):175-185. doi: 10.1038/s41563-018-0256-5. Epub 2019 Jan 14.

PMID:
30643235

Supplemental Content

Loading ...
Support Center